Clinical Trial Update: The CARDIO-TTRansform Scintigraphy Sub-study

View source ↗

Summary

An update on the CARDIO-TTRansform scintigraphy sub-study for transthyretin-mediated amyloid cardiomyopathy; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin-mediated Amyloid Cardiomyopathy

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) | Status: ACTIVE_NOT_RECRUITING